Epstein-Barr virus and human T-cell lymphomas

Seminars in Cancer Biology
C J MeijerA J van den Brule

Abstract

Epstein-Barr virus has been classically associated with certain B-lymphocytic benign and malignant proliferations. However, using molecular biological techniques it becomes clear that EBV is also associated with several T-NHL in non-immunocompromised patients. The distribution of EBV-associated T-NHL seems to be site-restricted, i.e. in about 100% of the nasal T-NHL and in 20% of the lung and gastrointestinal lymphomas and rarely in primary cutaneous T-cell lymphomas. Moreover, the expression of the LMP1 protein seems to be associated with a poor prognosis. In this section the role of EBV in the pathogenesis of T-NHL will be discussed.

Citations

Nov 25, 2000·Molecular Pathology : MP·L S YoungA G Eliopoulos
Oct 26, 2011·Pediatric Hematology and Oncology·Javier El-Bietar, Catherine Bollard
Apr 1, 2004·Expert Opinion on Therapeutic Patents·Astrid MeerbachPeter Wutzler
Apr 21, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D H Crawford
Feb 11, 2016·The Open Virology Journal·Abdelwahid Saeed AliIan M Jones
Jan 5, 2002·The Journal of Dermatology·J M Muche, W Sterr
Jan 1, 2009·Future Virology·Pankaj KumarErle S Robertson
Jul 1, 1997·Reviews in Medical Virology·N M Steven

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.